Release Date: 27/09/19 15:21 Summary: Company Secretary Appointment/Resignation Price Sensitive: No Download Document 796.6KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%